TFAP2B and neuroblastoma: Collectively, boosting AP-2β levels might represent a potential therapeutic approach, perhaps in combination with other anti-neuroblastoma therapies, to treat neuroblastoma, possibly through a localized drug delivery, which could minimize peripheral undesired effects.